Clinical trial will see if Apple devices can reduce the risk of strokes

Over the past several years, Apple has made efforts to expand the health-related features of the iPhone and Apple Watch. Apps and features like fall detection and high heart rate monitoring provide helpful insights, especially for senior citizens. La...

Lab-grown blood vessels could make dialysis easier

Dialysis, a common treatment for kidney disease, is far from pleasant, and companies and researchers are constantly working to improve the process. Now, researchers from Humacyte Inc., Duke University and Yale think they're one step closer to using b...

If Facebook’s Secret Study Bothered You, Then Quit Now


There are more than 1 billion Facebook users—I’m one of them—and the reality is that all of us are test subjects for the website’s not-so-grand experiments. ŸIs there a better way to get users...

Pfizer Starts Testing For Over-The-Counter Lipitor


Looking backward to improve its future, Pfizer will once again try to gain FDA approval to market its blockbuster drug, atorvastatin (Lipitor), over-the-counter (OTC). Peter Loftus reports in...

Rx For Software: Can Medidata Solutions Save Drug Companies Billions Of Dollars?


Tarek Sherif, a small-time fund manager, plopped his cathode-ray-tube monitor and desktop computer on an office chair and wheeled it a mile down Park Avenue from his fund’s offices into a small room...

American College of Cardiology Announces Late-Breaking Clinical Trials


The American College of Cardiology announced the lineup of late-breaking clinical trials for its upcoming annual meeting in Washington, DC. The opening session will include the most eagerly...

Johnson & Johnson Shares Clinical Trial Data


In a major victory for advocates of open access to data from clinical trials, Johnson & Johnson today announced that it will make all of its clinical trial data available to outside researchers....

Beyond Economics: How Price Controls Are Killing Millions Of Patients


Due to maximum-wage policies, it currently takes about a decade for working medical therapies to reach patients. Stronger incentives in the clinical trial process responsible for the delays would...
    






The Avorn-Stossel Debate On GSK Halting Payment To Doctors For Drug Promotion


GSK recently announced that it would no longer pay doctors to promote its drugs, a move that has generated a good deal of discussion.  The PBS Newshour entered the fray by featuring a debate between...